Search

everythinglearnresearchcommunity

for

Search:↓

Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

AGA linked to worse COVID-19 outcomes in men.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

COVID-19 can cause various skin issues, including rashes and lesions.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Hair loss doesn't affect COVID-19 severity.